World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 13 March 2023
Main ID:  NCT03443765
Date of registration: 16/02/2018
Prospective Registration: No
Primary sponsor: Research Institute of Epidemiology, Microbiology and Infectious Diseases, Uzbekistan
Public title: Serum 25(OH) Vitamin D and Total Serum Immunoglobulin E Levels in Patients With Pityriasis Alba
Scientific title: Serum 25(OH) Vitamin D and Total Serum Immunoglobulin E Levels in Patients With Pityriasis Alba
Date of first enrolment: May 1, 2017
Target sample size: 280
Recruitment status: Active, not recruiting
URL:  https://clinicaltrials.gov/show/NCT03443765
Study type:  Observational [Patient Registry]
Study design:   
Phase: 
Countries of recruitment
Uzbekistan
Contacts
Name:     Svetlana Osipova, MD, PhD, DS
Address: 
Telephone:
Email:
Affiliation:  research institute of epidemiology, microbiology and infectious diseases
Key inclusion & exclusion criteria

Inclusion Criteria:

- Patients with Pityriasis alba

- Healthy individuals (control group)

Exclusion Criteria:

- chronic and acute infectious diseases;

- endocrine diseases;

- congenital diseases;

- allergic dermatitis;

- bronchial asthma;

- allergic rhinitis and/or conjunctivitis;

- other skin disorders;

- history of using vitamin D supplements within three months ago, or use of any
medication influencing endocrine parameters.



Age minimum: 5 Years
Age maximum: 14 Years
Gender: All
Health Condition(s) or Problem(s) studied
Pityriasis Alba
Intervention(s)
Diagnostic Test: Detection of Total serum immunoglobulin E by ELISA technique
Diagnostic Test: Detection of Plasma levels of 25(OH) vitamin D by ELISA technique
Primary Outcome(s)
Serum 25(OH) vitamin D levels in the patients with pityriasis alba [Time Frame: up to 24 months]
Total serum immunoglobulin E levels in the patients with pityriasis alba [Time Frame: up to 24 months]
Secondary Outcome(s)
Secondary ID(s)
Project #002
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history